Tell your doctor right away if you (or your kid): could not be seeing as well as before starting SABRIL; start to trip, bump into things, or are more clumsy than usual how to pronounce vigabatrin; are surprised by individuals or points being available in front of you that seem ahead out of nowhere; or if your baby is acting differently than normal.

The Vigabatrin REMS Program is needed by the FDA to guarantee educated risk-benefit choices before starting treatment, and to ensure proper use of vigabatrin while patients are treated. It is not possible for your healthcare provider to know when vision loss will take place.

It is recommended that your healthcare provider test your (or your youngster's) vision before or within 4 weeks after beginning SABRIL and at least every 3 months throughout treatment up until SABRIL is stopped. Inform your healthcare provider if you or your child have any type of side effect that troubles you or that does not vanish.

If you are pregnant or intend to get expecting, tell your health care provider. If vision testing can not be done, your healthcare provider might proceed prescribing SABRIL, but will not have the ability to look for any vision loss. If vision tests are refrained frequently, your healthcare provider might stop suggesting SABRIL for you (or your kid).